arrow
T

Tayfun Güngör

University Children's Hospital Zurich
H指数:46
被引数:8,373

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial

FORUM试验中微量残留病对儿童急性淋巴细胞白血病造血干细胞移植结局的影响

2026-01-011
OA
Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan

二甲酰胺及其代谢物在经大剂量静脉注射白消安治疗的儿科患者中的药代动力学和毒性研究

2025-12-020
OAAI
Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT: results from the prospective FORUM study

低倍体或BCR::ABL1融合的B细胞急性淋巴细胞白血病儿童接受 allo HSCT 的结局:前瞻性FORUM研究的结果

Blood
IF23.1
2025-11-280
PRE
Hematopoietic stem-cell transplantation for Purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study

嘌呤核苷磷酸化酶缺乏症的血细胞干细胞移植:一项EBMT-IEWP回顾性研究

Blood
IF23.1
2025-09-240
OAAI
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMT

同种异基因造血细胞移植后HHV-6脑炎的临床特征与结局:EBMT感染性疾病工作组的研究

2025-06-030
PRE
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature

多组学分析揭示人类RAG缺陷症表现出独特的免疫失调模式,但具有共同的炎症特征

2025-01-010
OA
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study
LEUKEMIA
IF13.4
2024-11-190
PRE
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type-I

白细胞粘附缺陷症I型的异基因造血干细胞移植(allo-HSCT)结局

BLOOD
IF23.1
2024-11-050
PRE
Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

比较接受两种不同类型人抗T淋巴细胞球蛋白的儿童急性淋巴细胞白血病(ALL)患者,在造血干细胞移植前的结果:国际前瞻性论坛研究的结果

BLOOD
IF23.1
2024-11-050
PRE
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity
2024-09-271
OAAI
Ruxolitinib in treatment-naive or corticosteroid-refractory paediatric patients with chronic graft-versus-host disease (REACH5): interim analysis of a single-arm, multicentre, phase 2 study
2024-08-013
PRE
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM study
2024-01-122
OAAI
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021
2023-12-062
PRE
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial

前瞻性全SCT 2003试验的ALL长期随访儿童基于全身照射的同种异体HSCT后继发恶性肿瘤的发生率

LEUKEMIA
IF13.4
2022-09-1211
OAAI